In summary, these data support that catalytic inhibition of METTL3 contributes to autoantibody production and the lupus-like phenotype in cGVHD mice, potentially by promoting CD4+ T cell activation and affecting the imbalanced differentiation of effector T cells. Here, METTL3 is linked to systemic lupus erythematosus.